Paul Elvin

Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530

Tim P. Green, Mike Fennell, Robin Whittaker et al. · Molecular Oncology · 2009 · 256 citations · Full text

Medicine, Oncology, Pharmacology +10

Regional copy number–independent deregulation of transcription in cancer

Nicolas Stransky, Céline Vallot, Fabien Reyal et al. · Nature Genetics · 2006 · 253 citations

Medicine, Genetics, Molecular Genetics +10

A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in <i>PIK3CA</i> -Mutated Breast and Gynecologic Cancers

Udai Banerji, Emma Dean, José Alejandro Pérez Fidalgo et al. · Clinical Cancer Research · 2017 · 146 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors

José Baselga, Andrés Cervantes, Erika Martinelli et al. · Clinical Cancer Research · 2010 · 109 citations

Medicine, Oncology, Pharmacology +15

Isolation of cDNA clones using yeast artificial chromosome probes

Paul Elvin, G. Slynn, D. N. Black et al. · Nucleic Acids Research · 1990 · 80 citations · Full text

Life Sciences, Biotechnology, Genetics +12